glp 1 agonist crohn's disease Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential GLP-1 and GLP-2 Orchestrate Intestine
Description
Panagaki T, Gengler S, Hlscher C
#Healthcare #WeightLoss #MetabolicHealth #PublicHealth #Research To view or add a comment, sign in Sustaining healthy weight loss is about so much more than cutting calories or injecting drugs, as many GLP-1 users are finding out
Understanding each drug's mechanism helps explain why combining them remains largely experimental and requires physician discretion
doi: 10.2337/dc10-0612 12 HenryRRMurrayAVMarmolejoMHHennickenDPtaszynskaAListJF
Diabetes 65(1):3443
